相关实验视频

Updated: Jul 30, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

1.2K

在性小鼠中,TNF-α调解了气道过敏反应:thalidomide治疗的影响

Bianca Torres Ciambarella1, Glaucia Souza de Almeida1, Davidson Furtado Dias1

  • 1Laboratory of Inflammation / Institute Oswaldo Cruz Foundation (Fiocruz), Brazil.

European journal of pharmacology
|January 10, 2025
PubMed
概括

吸入的晶体二氧化在小鼠中引起肺部疾病和呼吸道过敏反应 (AHR),由TNF-α驱动. 塔利多米德通过抑制TNF-α生成,有效地阻断这些二氧化诱导的肺反应.

关键词:
气道的过度反应性纤维化 纤维化 纤维化化是一种化.这就是TNF-α.泰利多化物是一种

更多相关视频

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust10:45

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

2.1K
Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition06:12

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition

Published on: March 3, 2023

690

相关概念视频

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...